Auto Added by WPeMatico
Several NHS hospitals are preparing to use an AI-powered blood test to help assess women referred for possible womb cancer before invasive checks are carried out. According to The Guardian, around 90,000 postmenopausal women in England are referred by GPs each year for checks after experiencing heavy bleeding. About 10,000 women are diagnosed with womb […]
NHS AI blood test could reduce invasive womb cancer checks Read More »
Insilico Medicine is advancing to Phase III human trials for testing a drug identified by AI targeting idiopathic pulmonary fibrosis (IPF). This progression supplies the computational drug discovery sector with empirical test cases, advancing an AI medicine past early safety evaluations into late-stage efficacy validation. IPF destroys respiratory capacity through severe lung tissue scarring. Patients
Insilico Medicine advances AI drug for IPF to Phase III trials Read More »
L’Oreal is using AI to shorten product development timelines and identify new uses for ingredients already present in its portfolio. The French cosmetics group has applied AI in its laboratories for the past four years, with Fabrice Megarbane, president of L’Oreal’s consumer products division, telling Reuters that the technology helps the company predict how molecules
L’Oreal, Mondelez, and Nestle use AI to speed product development Read More »
Takeda has entered a strategic collaboration with Hong Kong-based Insilico Medicine to use AI in early-stage drug discovery across the Japanese pharmaceutical company’s therapeutic areas. The companies did not disclose which therapeutic areas or disease targets will be covered under the collaboration. The agreement gives Takeda access to Insilico’s Pharma.AI platform, which supports biological target
Takeda signs US$600M AI drug discovery deal with Insilico Read More »
Anthropic Claude Science now integrates the NVIDIA BioNeMo Agent Toolkit to accelerate computational life sciences research. Anthropic has launched the public beta of Claude Science, an AI workbench built for scientific research. The platform enables scientists to converse directly with digital agents using natural language to execute end-to-end research workflows. This system connects natively to
NVIDIA BioNeMo accelerates Anthropic Claude Science Read More »
Optimising retail AI infrastructure drives the successful deployment of personalisation systems and real-time customer insight. Leaders are replacing static customer interaction patterns with data pipelines capable of modifying the user environment during a live session. Static layouts and broad segmentation rules fail to satisfy modern conversion targets. Deployments demonstrate that traditional demographic categorisation generates insufficient
Deploying retail AI to scale personalisation and customer insight Read More »
Anthropic has launched Claude Sonnet 5 and restored access to its Fable and Mythos frontier models following a federal export control review. The decision marks the conclusion of an eighteen-day operational pause triggered by a US government export control directive on June 12, which forced the temporary suspension of Anthropic’s highest-capability systems. Government officials enacted
Anthropic deploys Claude Sonnet 5, Fable and Mythos restored Read More »
HP has scaled its OpenAI Frontier integration across global operations to optimise enterprise workflows and accelerate output. The hardware manufacturer initiated testing of the platform in February 2026. Early pilot programs yielded verified operational gains in software engineering and cybersecurity remediation. Expanding these initial trials into an enterprise-wide operating model requires connecting access protocols, contextual
HP accelerates enterprise workflows with OpenAI Frontier Read More »
SAP aligns fragmented commerce data structures to enable operational AI personalisation at the execution layer. Enterprise leadership routinely establishes objectives to anticipate customer requirements and deliver relevant interactions across digital touchpoints. However, the actual infrastructure running inside these enterprises fails to support systematic execution at the required volume. Recommendation engines display generic product listings because
Omio integrates OpenAI models across its engineering operations to accelerate travel product development and launch booking interfaces. The multimodal travel platform coordinates operations with over 3,000 transportation providers across 47 countries. Omio explicitly rejects the superficial addition of technology to outdated internal processes. The company’s CTO, Tomas Vocetka, requires all internal functions to completely redesign
Omio scales travel product development using OpenAI models Read More »
